• About us
• Contact

Advertisement

Organisation › Details

Data and Safety Monitoring Board (DSMB)*

	City	n. a.
		Address record changed: 2011-05-15
Basic data	Employees	n. a.
		Record changed: 2023-11-25

Advertisement

More documents for Data and Safety Monitoring Board (DSMB)*

• [1] InDex Pharmaceuticals Holding AB. (11/21/23). "Press Release: InDex Pharmaceuticals Discontinues Cobitolimod Phase III Program"....
• [2] Bone Therapeutics S.A.. (11/6/18). "Press Release: Bone Therapeutics Announces Conclusions from Interim Analysis of Phase III PREOB Study in Hip Osteonecrosis". Gosselies....
• [3] 4SC AG. (2/1/18). "Press Release: Positive DSMB Safety Review of 4SC’s Pivotal RESMAIN Study of Resminostat in CTCL". Planegg-Martinsried....
• [4] Bayer AG. (11/30/17). "Press Release: Phase III Trial of Radium-223 Dichloride in Combination with Abiraterone Acetate and Prednisone/Prednisolone for Patients with Metastatic Castration-resistant Prostate Cancer Unblinded Early [Not intended for U.S. an...
• [5] Bavarian Nordic A/S. (9/14/17). "Press Release: Independent Data Monitoring Committee Recommends Discontinuation of Bavarian Nordic’s Phase 3 Study of Prostvac in Metastatic Prostate Cancer". Copenhagen....
• [6] Neovacs S.A.. (2/3/17). "Press Release: Neovacs Announces Independent Data and Safety Monitoring Board Supports Continuation of Phase IIb Clinical Trial for IFNa Kinoid in Lupus". Paris....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2023. Made in Germany.